Myasthenia Gravis Treatment Landscape Rapidly Evolving : vim

Approximately 70 to 300 million individuals worldwide are living with myasthenia gravis, an antibody-mediated autoimmune disorder that adversely affects neuromuscular junction function.

Related Keywords

United Kingdom , British , , Alexion Myasthenia Gravis Foundation Of America , Association Of British Neurologist , Association Of British Neurologists , British Neurologist , Vaccine Clinical Trials , Image Credit , Rituximab In Myasthenia , Refractory Generalized Myasthenia Gravis , Efficacy Study , Adults With Generalized Myasthenia , Myasthenia Gravis Foundation , Subjects With Generalized Myasthenia Gravis , Safety Study , Test Efficacy , Adult Patients With Generalized Myasthenia , Accessed September , Autoantibodies , Monoclonal Antibody , Musk Mg , Achr Gmg ,